COMPANY PROFILE

Jumpcode Genomics

Explore full profile

Innovative CRISPRclean technology enhancing genomic data accuracy by reducing noise and increasing informative reads

San Diego, United StatesFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Jumpcode Genomics

Jumpcode Genomics operates in the biotechnology sector, focusing on enhancing the accuracy of genomic data through its proprietary CRISPRclean technology. This technology significantly reduces noise in genetic sequencing, allowing researchers to obtain more informative reads from their data. The company primarily serves academic institutions, research organizations, and biotech firms that require precise genomic data for their studies and product development. Jumpcode Genomics generates revenue by selling its CRISPRclean kits and related products, which improve the sensitivity and depth of genomic reads. The business model is based on direct sales and partnerships with research entities. By providing tools that double the amount of useful genetic information, Jumpcode Genomics helps accelerate scientific discovery and innovation in the field of genomics.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: San Diego, United States
Employees: 7
Open positions: None listed
Dealroom signal: 58.8/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jan 2021	$21M	$84M	Arboretum Ventures · Baird Capital · LYZZ Capital · Robert W. Baird & Co.	—
SEED✓Equity / VC	Sep 2018	$2.5M	$10M	Undisclosed	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Jumpcode Genomics website traffic

Latest recorded traffic for Jumpcode Genomics is 1.5K monthly website visits, up 7.1% over the last three months. Jumpcode Genomics's team declined 36.4% over the past year.

Latest monthly visits1.5K 3-month web change+7.1% 1-year team growth-36.4%

Monthly website visitsDec 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CLClexBioA biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with proprietary hydrogel technology	Oslo, Norway	Operational	9	$2.3M	$4.8M
LALarondePioneering a completely novel translatable RNA platform - Endless RNA (eRNA)	Cambridge, United States	Operational
IAImmunito AIAn in-silico Antibody Discovery company which uses Artificial Intelligence to give the fastest and most accurate solutions	Bengaluru, India	Operational
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational
ASASYLIACompanion Diagnostics For Immunotherapy \| Asylia Diagnostics	Beerse, Belgium	Operational
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational